c="Fabry disease" 1:4 1:5||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="alpha-galactosidase A" 1:19 1:20||t="medication"||cui="C0002268"||tot="Alpha-galactosidase"||ns="-734"
c="Fabry disease" 2:8 2:9||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="examined" 2:20 2:20||t="problem"||cui="C0332128"||tot="Examined"||ns="-1000"
c="angiokeratotic skin lesions" 2:34 2:36||t="problem"||cui="C0037284"||tot="Skin lesion"||ns="-867"
c="isoelectric focusing" 2:53 2:54||t="test"||cui="C0022169"||tot="Isoelectric Focusing"||ns="-1000"
c="Fabry disease" 2:64 2:65||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="codon 341 GAA-AAA" 2:103 2:105||t="test"||cui="C1422135"||tot="AAAS gene"||ns="-779"
c="alpha-galactosidase" 2:108 2:108||t="medication"||cui="C0002268"||tot="Alpha-galactosidase"||ns="-1000"
